Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib, Cyclophosphamide and Dexamethasone in Primary Systemic Light Chain Amyloidosis
NCT01072773Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in primary systemic light chain amyloidosis, sponsored by Mayo Clinic. Started Mar 2010; status: completed.
02
Drugs
bortezomib
03
Conditions
primary systemic light chain amyloidosis
Beyond the preview
Go deeper on NCT01072773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072773.